Navidea Biopharmaceutica (Israel) Price Prediction and Hype Density Breakdown

NAVB -- Israel Stock  

ILS 49.30  2.00  4.23%

We analyze noise-free headlines and recent hype associated with Navidea Biopharmaceuticals which may create opportunities for some arbitrage if properly timed. With Navidea Biopharmaceutica hype-based prediction module you can estimate the value of Navidea Biopharmaceuticals from the prospective of Navidea Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Navidea Biopharmaceutica over a specific investment horizon. Please see also Stocks Correlation.
Horizon     30 Days    Login   to change

Navidea Biopharmaceutica After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Navidea Biopharmaceutica Estimiated After-Hype Price Volatility

March 22, 2019
Current Value
After-hype Price
Target Odds
Odds Odds
Navidea Biopharmaceutica is Unknown risk asset. Analysis and calculation of next after-hype price of Navidea Biopharmaceutica is based on 2 months time horizon.

Navidea Biopharmaceutica Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.00% 0.00% 0.00%  0.00% 1 Events / Month5 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Navidea Biopharmaceutica Hype Timeline

Navidea Biopharmaceutica is now traded for 49.30on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Navidea Biopharmaceuticals is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at 0.0%. The volatility of relative hype elasticity to Navidea Biopharmaceutica is about 0.0%%. The volatility of related hype on Navidea Biopharmaceutica is about 0.0% with expected price after next announcement by competition of 49.3. About 35.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 197.2. Navidea Biopharmaceutica recorded loss per share of 0.1. The entity had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be very soon.
Please see also Stocks Correlation.

Navidea Biopharmaceutica Related Hype Analysis

At Risk
Delek Drilling Limited Partnership 1.00 2 per month 2.33 (0.0414)  3.25 (3.52)  9.23 
Suny Electronic Inc Ltd 0.00 1 per month 0.38  0.0095  2.30 (1.28)  6.13 
Alony Hetz Properties Investments Ltd 16.00 1 per month 0.88  0.06  2.10 (1.29)  6.53 
LivePerson(134.00) 6 per month 2.91  0.18  7.08 (5.51)  14.49 
Airport City Ltd(16.00) 4 per month 1.26 (0.0012)  2.46 (1.91)  6.94 
Tower Semiconductor Ltd(60.00) 4 per month 2.11  0.06  5.75 (4.80)  19.38 
Shufersal Ltd 0.00 0 per month 0.00 (0.12)  2.60 (3.01)  8.07 
Paz Oil Company Ltd(250.00) 6 per month 0.00 (0.17)  2.74 (1.94)  8.70 
The Phoenix Holdings Ltd 52.00 4 per month 1.83 (0.06)  3.56 (3.43)  8.27 
Shapir Engineering and Industry Ltd(2.00) 1 per month 1.66 (0.025)  3.58 (3.17)  9.94 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 20 shares
Active 2 days ago
Purchased over 400 shares
Active 2 days ago
Purchased over 40 shares
Active 2 days ago
Purchased few shares
Active 2 days ago
Purchased a lot of shares
Active 2 days ago
Purchased over 40 shares
Active 2 days ago
Please see also Stocks Correlation. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.